Department of Thoracic Surgery, Hospital Universitario Marqués de Valdecilla, Servicio de Cirugía Torácica, Avda. de Valdecilla 25, Santander (Cantabria), Spain.
Respir Med. 2010 Dec;104(12):1929-36. doi: 10.1016/j.rmed.2010.08.007.
Large-cell neuroendocrine carcinoma is an aggressive variant of large-cell carcinoma of the lung, which has poor survival in most series, resembling that of small-cell lung carcinoma. We report our retrospective assessment of surgically-resected cases of both tumours.
33 large-cell neuroendocrine carcinomas and 16 peripheral small-cell lung carcinomas were reassessed retrospectively. Survival rates of both tumours in surgically-resected cases were calculated and compared using Kaplan-Meier survival curves and Log Rank test, respectively.
In large-cell neuroendocrine carcinomas, there were 25 patients with pathologic stage I, 4 with pathologic stage II and 4 with pathologic stage III. In small-cell lung carcinomas, there were 6 patients with pathologic stage I, 3 with pathologic stage II and 7 with pathologic stage III. 12% of large-cell neuroendocrine carcinomas and 62.5% of small-cell lung carcinomas were of advanced disease. The mean follow-up was 89 months. The actuarial survival for the 2 groups was not significantly different.
Large-cell neuroendocrine carcinomas of the lung have poor prognosis even in early stages, with survival rates similar to that of small-cell lung carcinomas.
大细胞神经内分泌癌是肺大细胞癌的一种侵袭性变异型,在大多数系列中生存状况较差,类似于小细胞肺癌。我们报告了对两种肿瘤的回顾性评估。
重新评估了 33 例大细胞神经内分泌癌和 16 例周围型小细胞肺癌。使用 Kaplan-Meier 生存曲线和 Log Rank 检验分别计算并比较了两种肿瘤在手术切除病例中的生存率。
在大细胞神经内分泌癌中,有 25 例患者为病理 I 期,4 例为病理 II 期,4 例为病理 III 期。在小细胞肺癌中,有 6 例为病理 I 期,3 例为病理 II 期,7 例为病理 III 期。12%的大细胞神经内分泌癌和 62.5%的小细胞肺癌为晚期疾病。平均随访时间为 89 个月。两组的实际生存率无显著差异。
即使在早期阶段,肺大细胞神经内分泌癌的预后也较差,生存率与小细胞肺癌相似。